AU2513997A - Diagnosis and monitoring of neurological disease - Google Patents
Diagnosis and monitoring of neurological diseaseInfo
- Publication number
- AU2513997A AU2513997A AU25139/97A AU2513997A AU2513997A AU 2513997 A AU2513997 A AU 2513997A AU 25139/97 A AU25139/97 A AU 25139/97A AU 2513997 A AU2513997 A AU 2513997A AU 2513997 A AU2513997 A AU 2513997A
- Authority
- AU
- Australia
- Prior art keywords
- diagnosis
- monitoring
- neurological disease
- neurological
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96486—Metalloendopeptidases (3.4.24)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9607287.1A GB9607287D0 (en) | 1996-04-09 | 1996-04-09 | Diagnosis method |
GB9607287 | 1996-04-09 | ||
PCT/GB1997/000975 WO1997038314A1 (en) | 1996-04-09 | 1997-04-08 | Diagnosis and monitoring of neurological disease |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2513997A true AU2513997A (en) | 1997-10-29 |
Family
ID=10791724
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU25139/97A Abandoned AU2513997A (en) | 1996-04-09 | 1997-04-08 | Diagnosis and monitoring of neurological disease |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2513997A (en) |
GB (1) | GB9607287D0 (en) |
WO (1) | WO1997038314A1 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9809764D0 (en) * | 1998-05-07 | 1998-07-08 | Isis Innovation | MMP-9 Gene polymorphisms |
WO2000020860A1 (en) * | 1998-10-08 | 2000-04-13 | Calbiochem Novabiochem Corporation | Diagnostic assay for matrix metalloproteinase 9 and use thereof |
US7374886B2 (en) | 1999-04-09 | 2008-05-20 | Rigshospitalet | Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker and postoperative marker for minimal residual disease or recurrent disease in patients with a prior history of cancer |
AU771309B2 (en) | 1999-04-09 | 2004-03-18 | Rigshospitalet | Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker |
GB9927576D0 (en) * | 1999-11-23 | 2000-01-19 | Univ Birmingham | Novel assay |
EP2275817A1 (en) * | 2000-05-17 | 2011-01-19 | Nederlandse Organisatie voor toegepast -natuurwetenschappelijk onderzoek TNO | Proteolytic enzymes in diagnosis of kidney disorders |
EP1782068B1 (en) | 2004-07-23 | 2010-04-07 | Centre de Recherche Public de la Santé | Monitoring heart failure |
US10626399B2 (en) | 2010-01-28 | 2020-04-21 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of treating cognitive symptoms of an aging-associated impairment by modulating C-C chemokine receptor type 3 (CCR3) |
US10487148B2 (en) | 2010-01-28 | 2019-11-26 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for treating aging-associated impairments |
US20160208011A1 (en) | 2010-01-28 | 2016-07-21 | The Board Of Trustees Of The Leland Stanford Junior University | Ccr3 modulation in the treatment of aging-associated impairments, and compositions for practicing the same |
US9161968B2 (en) | 2011-04-08 | 2015-10-20 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of neuroprotection involving macrophage colony stimulating factor receptor agonists |
US10905779B2 (en) | 2013-12-09 | 2021-02-02 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for screening human blood products comprising plasma using immunocompromised rodent models |
EP3079708A4 (en) | 2013-12-09 | 2017-08-30 | The Board of Trustees of the Leland Stanford Junior University | Methods and compositions for treating aging-associated conditions |
DK3307296T3 (en) | 2015-06-15 | 2021-12-13 | Univ Leland Stanford Junior | TIMP2 FOR USE IN THE TREATMENT OF AGING ASSOCIATED CONDITIONS |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0464147B1 (en) * | 1989-03-21 | 2002-06-26 | THE UNITED STATES OF AMERICA as represented by the Secretary UNITED STATES DEPARTMENT OF COMMERCE | Matrix metalloproteinase inhibitor peptides |
US5324634A (en) * | 1992-03-31 | 1994-06-28 | The Research Foundation Of State University Of New York | Diagnostic tests measuring gelatinase/inhibitor complexes for detection of aggressive and metastatic cancer |
EP0670849B1 (en) * | 1992-10-29 | 2003-08-27 | Bayer Corporation | Diagnostic assay for latent matrix metalloproteinase no. 9 |
AU7827794A (en) * | 1993-08-12 | 1995-03-14 | Regents Of The University Of California, The | Human timp-3 |
US5641636A (en) * | 1994-05-20 | 1997-06-24 | University Of Pennsylvania | Method of predicting fetal membrane rupture based on matrix metalloproteinase-9 activity |
-
1996
- 1996-04-09 GB GBGB9607287.1A patent/GB9607287D0/en active Pending
-
1997
- 1997-04-08 AU AU25139/97A patent/AU2513997A/en not_active Abandoned
- 1997-04-08 WO PCT/GB1997/000975 patent/WO1997038314A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
GB9607287D0 (en) | 1996-06-12 |
WO1997038314A1 (en) | 1997-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6744798A (en) | Health condition monitor and method of use | |
AU5312496A (en) | Partially disposable surgical imaging assembly | |
AU4349097A (en) | Non-invasive imaging of biological tissue | |
AU3228695A (en) | Non-invasive blood analyte sensor | |
AU2513997A (en) | Diagnosis and monitoring of neurological disease | |
EP0736761A3 (en) | Engine diagnostic monitor | |
GB9624411D0 (en) | Diagnosis of prion diseases | |
AU9086898A (en) | Remote monitoring of physiological condition | |
AU6336096A (en) | Non-invasive uterine activity sensor | |
AU1450997A (en) | Physiological movement monitoring | |
AU4418096A (en) | Diagnosis of pancreatitis | |
IL117146A0 (en) | Diagnosis of lung condition | |
AU2909495A (en) | Evaluation of blood coagulation activity | |
AU7260098A (en) | Diagnosis and treatment of phosphatase 0r kinase-related disorders | |
AU7201696A (en) | Method of diagnosing crohn's disease | |
AU2913397A (en) | Method and system for non-invasive determination of the main cardiorespiratory parameters of the human body | |
AU4977496A (en) | Human neuronal attachment factor-1 | |
AU4670696A (en) | Diagnosis of toxicoinfectious clostridiosis | |
AU4841296A (en) | Diagnosis of and compositions and methods for the treatment of disease | |
AU2037800A (en) | Diagnosis of human glycosylation disorders | |
AU6852896A (en) | Diagnosis and treatment of neurological disease | |
AU7143996A (en) | Method for the diagnosis of coeliac disease | |
AU2969795A (en) | Video and analog monitoring and diagnosis system | |
AU4455596A (en) | Non-invasive medical sensor | |
GB9406577D0 (en) | Diagnosis and treatment of degenerative disease |